State Street Corp Anavex Life Sciences Corp. Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, State Street Corp holds 7,299,007 shares of AVXL stock, worth $30 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,299,007
Previous 3,642,702
100.37%
Holding current value
$30 Million
Previous $33.9 Million
9.55%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding AVXL
# of Institutions
159Shares Held
31.6MCall Options Held
910KPut Options Held
1.35M-
Black Rock Inc. New York, NY6.65MShares$27.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$18.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.71MShares$7.04 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC851KShares$3.5 Million0.0% of portfolio
-
Nwam LLC Mercer Island, WA837KShares$3.44 Million0.35% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $320M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...